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(57) ABSTRACT 
Kayden, 
Systems and methods for providing an optimal treatment 
plan for delivering a prescribed radiation dose to a pre-
defined target volume within a patient using an external 
beam radiation delivery unit are provided. The systems have 
an interface which is adapted to receive information related 
to a prescribed radiation dose, a predefined target volume 
within a patient, and parameters associated with an external 
beam delivery unit. The systems also have a treatment plan 
modeling processor which is adapted to receive all of the 
input data and develop a treatment plan optimization model 
defining a global system. The systems also have an optimi-
zation processor which is adapted to determine an optimal 
treatment plan based on the treatment plan optimization 
model and all the input data. 
3 Claims, 4 Drawing Sheets 
Determine optimal solution to 
global mathematical expression 
using branch-and-bound 
algorithm 
Determine dose calculation 
optimization model incorporating 
variables, constraints, and 
clinical objective into global 
mathematical expression 
46 
Determine type for each variable 
to include in dose calculation 
optimization model (non-
negative continuous variable or 
0/1 integer variable 
44 
Determine variables to include 1n 
dose calculation optimization 
model 
I 
Receive predefined clinical 


















































. I I 
I 22__.-' I 


































































- - I 











































°' ""-l .i;;.. 
~ 
N 








I . . 













...J - w < ~ ...J 
CD N ::> 
o-o 
....I :E 0 





z ....I w 
w w ...J 
:E 0 ::> 
t-Oo 
< :E 0 


















































U.S. Patent May 25, 2004 Sheet 4 of 4 US 6,741,674 B2 
Determine optimal solution to 





Receive information related to 
~ 
Determine dose calculation 
the target volume (e.g. spatial optimization model incorporating 
orientation of target volume, !) variables, constraints, and surrounding normal tissue, clinical objective into global 
proximal critical structures) 36 mathematical expression 
46 
Receive information related to "'-parameters associated with \) Determine type for each variable external beam delivery unit 
to include in dose calculation 
38 optimization model (non-
negative continuous variable or 
,,. 0/1 integer variable 
Receive information related to 
40 the constraints to be 
L/ incorporated into dose calculation optimization model 44 
(e.g. dosimetric constraints, ~ Determine variables to include in 
beam geometry and parameter dose calculation optimization 
constraints) model 
I 
Receive predefined clinical 




US 6,741,674 B2 
1 
SYSTEMS AND METHODS FOR GLOBAL 
OPTIMIZATION OF TREATMENT 
PLANNING FOR EXTERNAL BEAM 
RADIATION THERAPY 
CROSS REFERENCE TO RELATED 
APPLICATIONS 
This application is a continuation application, which is 
based on and claims priority to U.S. Utility patent applica-
tion Ser. No. 09/706,915, filed on Nov. 6, 2000 now U.S. Pat. 
No. 6,546,073, which is based on and claims priority to U.S. 
Provisional Patent Application No. 60/164,029 filed on Nov. 
5, 1999, each of which are hereby incorporated by reference 
in their entirety. This application also claims priority to U.S. 
Provisional Application No. 60/433,657, filed Dec. 18, 
2002, which is hereby incorporated by reference in its 
entirety. 
FIELD OF THE INVENTION 
The present invention relates generally to treatment plan-
ning for external beam radiation therapy, and more 
particularly, to systems and methods for global optimization 
of treatment planning for external beam radiation therapy. 
BACKGROUND OF THE INVENTION 
External beam radiation therapy is a well-known treat-
ment option available to the radiation oncology and neuro-
surgery communities for treating and controlling certain 
central nervous systems lesions, such as arteriovenous 
malfomations, metastatic lesions, acoustic neuromas, pitu-
itary tumors, malignant gliomas, and other intracranial 
tumors. As the name implies, the procedure involves the use 
of external beams of radiation directed into the patient at the 
lesion using either a gamma unit (referred to as a Gamma 
Knife), a linear accelerator, or similar beam delivery appa-
ratus. Although treating the lesions with the radiation pro-
vides the potential for curing the related disorder, the prox-
imity of critical normal structures and surrounding normal 
tissue to the lesions makes external beam radiation therapy 
an inherently high risk procedure that can cause severe 
complications. Hence, the primary objective of external 
beam radiation therapy is the precise delivery of the desired 
radiation dose to the target area defining the lesion, while 
minimizing the radiation dose to surrounding normal tissue 
and critical structures. 
The process of treating a patient using external beam 
radiation therapy consists of three main stages. First, a 
precise three-dimensional map of the anatomical structures 
in the location of interest (target volume) is constructed 
using any conventional three-dimensional imaging 
technology, such as computed tomography (CT) or magnetic 
resonance imaging (MRI). Second, a treatment plan is 
developed for delivering a predefined dose distribution to 
the target volume that is acceptable to the clinician. Finally, 
the treatment plan is executed using an accepted beam 
delivery apparatus. 
Thus, the basic strategy of external beam radiation 
therapy is to utilize multiple beams of radiation from mul-
tiple directions to "cross-fire" at the target volume. In that 
way, radiation exposure to normal tissue is kept at relatively 
low levels, while the dose to the tumor cells is escalated. 
Thus, the main objective of the treatment planning process 
involves designing a beam profile, for example, a collection 
of beams, that delivers a necrotic dose of radiation to the 
tumor volume, while the aggregate dose to nearby critical 
2 
structures and surrounding normal tissue is kept below 
established tolerance levels. 
One existing method for treatment planning in external 
beam radiation therapy is standard manual planning. This 
5 method is referred to as forward planning because the 
physician solves the direct problem of determining the 
appropriate dose distribution given a known set of beam 
characteristics and beam delivery parameters. In other 
words, standard manual planning involves a trial-and-error 
10 approach performed by an experienced physician. The phy-
sician attempts to create a plan that is neither complex nor 
difficult to implement in the treatment delivery process, 
while approximating the desired dose distribution to the 
greatest extent possible. For instance, the physician may 
15 choose how many isocenters to use, as well as the location 
in three dimensions, the collimator size, and the weighting 
to be used for each isocenter. A treatment planning computer 
may calculate the dose distribution resulting from this 
preliminary plan. Prospective plans are evaluated by view-
20 ing isodose contours superimposed on anatomical images 
and/or with the use of quantitative tools such as cumulative 
dose-volume histograms (DVH's). 
Standard manual planning has many disadvantages. This 
iterative technique of plan creation and evaluation is very 
25 cumbersome, time-consuming, and far from optimal. Thus, 
manual planning results in much higher costs for patients 
and insurers. The physician or other experienced planner can 
evaluate only a handful of plans before settling on one. Thus, 
standard planning has very limited success in improving 
30 local tumor control or reducing complications to normal 
tissue and critical structures, and as a result, greatly limits 
the quality-of-life for patients. In standard manual planning, 
there is no mechanism for allowing the advance imposition 
of clinical properties, such as, for example, an upper bound 
35 on dose received by normal tissue or the specific shape of 
dose-response curves to the tumor and to critical structures, 
on the resulting plans. Furthermore, manual planning is 
subjective, inconsistent, far from optimal, and only enables 
a small amount of treatment plans to be examined by the 
40 physician. 
Another method for treatment planning in external beam 
radiation therapy employs computer systems to optimize the 
dose distributions specified by physicians based on a set of 
preselected variables. This approach is known as inverse 
45 planning in the medical community because the computer 
system is used to calculate beam delivery parameters that 
best approximate the predetermined dose, given a set of 
required doses, anatomical data on the patient's body and the 
target volume, and a set of preselected or fixed beam 
50 orientation parameters and beam characteristics. In order to 
solve the complex problem of arriving at an optimal treat-
ment plan for the domain of possible variables, all existing 
methods of inverse treatment planning fix at least a subset of 
the set of variables. For example, a particular modality of 
55 external beam radiation therapy may include the following 
domain of possible variables: (1) number of beams, (2) 
configuration of beams, (3) beam intensity, ( 4) initial gantry 
angle, (5) end gantry angle, (6) initial couch angle, (7) end 
couch angles, (8) prescription dose, (9) target volume, and 
60 (10) set of target points. State of the art inverse treatment 
planning approaches preselect a subset of these variables 
and fix them during the optimization calculation. 
Despite its obvious advantages over the standard manual 
approach, existing inverse treatment planning approaches 
65 have several disadvantages and inadequacies. As described 
above, these approaches do not incorporate each of the 
domain of possible variables into the optimization calcula-
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tion. Instead, these approaches fix at least a subset of these 
variables to arrive at an "optimal" treatment plan. This type 
of "local optimization" is inherently problematic because it 
does not allow the full flexibility of choosing different beam 
geometries, beam orientation parameters, and beam 
parameters, imposing dose limits, and placing constraints on 
physical planning parameters. In other words, these 
approaches do not enable "global optimization" of treatment 
planning for external beam radiation therapy. Therefore, 
these approaches are limited by "less than optimal" treat-
ment plans and, consequently, are unable to adequately 
control tumor growth or reduce normal tissue complications. 
Furthermore, there are an infinite number of possible treat-
ment plans in inverse treatment planning, and existing 
methods only look at a small subset of potential plans and 
select the "best" from the subset. Thus, the resulting treat-
ment plan is not a globally optimal plan. 
Furthermore, existing inverse treatment planning are not 
well-suited for use with newer external beam radiation 
therapy modalities. Recent technological advances have 
resulted in sophisticated new devices and procedures for 
external beam radiation delivery, such as, for example, 
high-resolution multi-leaf collimators, intensity-modulated 
radiation therapy (IMRT), and non-coplanar arc stercotactic 
radiosurgery (NASR). Unlike conventional radiation 
therapy where radiation profiles are altered via the use of a 
limited number of wedges, beam blocks and compensating 
filters, these new devices and procedures allow a large 
collection of beams to be shaped in any desired fashion with 
regard to both the geometrical shape and fluence across the 
field to create fixed or moving nonuniform beams of photons 
4 
main components. The systems have an interface which is 
adapted to receive information related to a prescribed radia-
tion dose, information related to a predefined target volume 
within a patient, and information related to parameters 
5 associated with an external beam delivery unit. The systems 
also have a treatment plan modeling module which is 
adapted to receive all of the input data and develop a 
treatment plan optimization model. Employing a true global 
optimization approach, the treatment plan optimization 
10 model incorporates all of the physical and clinical variables 
related to the external beam delivery unit and the target 
volume that define the global system. The systems also have 
a global optimization module which is adapted to determine 
an optimal treatment plan based on the treatment plan 
15 optimization model and all the input data. The systems may 
also include a visual evaluation functionality which is 
adapted to display information related to the optimal treat-
ment plan to a physician. 
The present invention can also be viewed as providing 
20 methods for providing an optimal treatment plan for deliv-
ering a prescribed radiation dose to a predefined target 
volume within a patient using an external beam radiation 
delivery unit. Briefly, one such method involves (1) receiv-
ing information related to the prescribed radiation dose, the 
25 predefined target volume, and parameters associated with 
the external beam delivery unit, (2) developing a treatment 
plan optimization model based on a plurality of variables 
corresponding to the information, and (3) outputting an 
optimal treatment plan based on the treatment plan optimi-
30 zation model and the information. 
or charged particles. While the flexibility and precise deliv-
ery capability resulting from these advances is clearly 
advantageous, their full potential cannot be realized using 
"local optimization" schemes which do not incorporate each 35 
of the domain of possible variables into the optimization 
calculation, but instead fix at least a subset of these variables 
Other systems, methods, features, and advantages of the 
present invention will be or become apparent to one with 
skill in the art upon examination of the following drawings 
and detailed description. It is intended that all such addi-
tional systems, methods, features, and advantages be 
included within this description, be within the scope of the 
present invention, and be protected by the accompanying 
claims. to arrive at an "optimal" treatment plan. 
Thus, an unaddressed need exists in the industry to 
address the aforementioned deficiencies and inadequacies. 40 
SUMMARY OF THE INVENTION 
BRIEF DESCRIPTION OF THE DRAWINGS 
The systems and methods according to the present inven-
tion can be better understood with reference to the following 
drawings. The present invention solves the problems described 
above by providing systems and methods for providing a 
globally optimal treatment plan for delivering a prescribed 
radiation dose to a target tumor volume within a patient 
using an external beam radiation source. The present inven-
tion enables a physician performing external beam radiation 
therapy to develop a globally optimal treatment plan, which 
results in improved patient care and improved efficiency. For 
example, in the field of external beam radiation therapy, the 
present invention reduces normal tissue complications, 
improves tumor control, enables physicians to evaluate a set 
45 
FIG. 1 is a functional block diagram of one embodiment 
of a system according to the present invention. 
FIG. 2 is a functional block diagram of another embodi-
ment of a system according to the present invention. 
FIG. 3 is a block diagram of a preferred implementation 
50 of the system illustrated in FIG. 2. 
of globally optimal solutions, reduces the time and cost 55 
associated with producing a treatment plan, eliminates trial 
and error visual optimization, enables physicians to perform 
radiation therapy in complex situations, such as where 
critical structures are near the tumor, improves the percent-
age of tumor volume covered by a prescription isodose line, 60 
reduces the ratio of the maximum dose to the prescribed 
dose, improves the ratio of the volume of the prescribed 
isodose surface to the target volume, and improves the ratio 
of the maximum dose received by normal tissue to the 
prescribed dose. 
Briefly described, the systems according to the present 
invention for providing an optimal treatment plan have three 
65 
FIG. 4 is a flowchart illustrating the functionality and 
operation of the system illustrated in FIGS. 2 and 3. 
DETAILED DESCRIPTION OF THE 
INVENTION 
Having summarized the invention above, reference is now 
made in detail to the description of the invention as illus-
trated in the drawings. While the invention will be described 
in connection with these drawings, there is no intent to limit 
it to the embodiment or embodiments disclosed. On the 
contrary, the intent is to cover all alternatives, modifications 
and equivalents included within the spirit and scope of the 
invention as defined by the appended claims. 
System Overview 
FIG. 1 illustrates a functional block diagram of a preferred 
embodiment of a system 10 according to the present inven-
US 6,741,674 B2 
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tion for enabling global optimization of treatment planning 
for external beam radiation therapy. System 10 is connected 
to an external beam delivery unit 12, visual evaluation 
functionality 14, and three-dimensional imaging system 16. 
External beam delivery unit 12 may be any conventional 
equipment used in external beam radiation therapy for 
delivering doses of radiation to a target volume 20 within a 
patient, such as, for example, a linear accelerator (LINAC), 
6 
adding intensity modulation allows more intense treatment 
of the tumor, while limiting the radiation dose to adjacent 
healthy tissue. 
IMAT is a form of IMRT that involves gantry rotation and 
5 dynamic multileaf collimation. Non-coplanar or coplanar 
arc paths are chosen to treat the target volume delineated 
from CT images. The arcs are chosen such that intersecting 
a critical structure is avoided. The fiuence profiles at every 
5 degrees arc similar to a static IMRT field. As the gantry a Gamma Knife, or any other external device capable of 
providing a radiation source. External beam delivery unit 12 
may comprise a plurality of external beams having variable 
intensity, a plurality of collimators for adjusting the size of 
the beams, and a mechanism for moving the unit with 
respect to a patient positioned within a stereotactic frame in 
order to adjust the angle and entry point of each radiation 15 
beam. 
10 rotates, the dynamic MLC modulates the intensity to deliver 
the dose to the target volume while sparing normal tissue. 
The large number of rotating beams may allow for a more 
conformal dose distribution than the approach of multiple 
intensity modulated beams. 
Thus, the systems and methods of the present invention 
are not limited to a particular type of external beam delivery 
unit 12 or a particular modality, but instead may employ any 
type of external beam delivery unit or radiation modality. 
Visual evaluation functionality 14 may be any conven-
System 10 also contemplates using various radiation 
modalities with external beam delivery unit 12. For 
example, system 10 may be used with static conformal 
radiation therapy (SCRT), non-coplanar arc stereotactic 
radiosurgery (NASR), intensity modulated radiation therapy 
(IMRT), and intensity modulated arc therapy (IMAT). 
SCRT involves the use of three-dimensional computer 
planning systems to geometrically shape the radiation field 
to ensure adequate coverage of the target, while sparing 
normal tissue. The tools for SCRT include patient-specific 
CT data, beam's-eye-view (BEV) treatment planning, and 
multileaf collimators (MLC). Guided by the target contours 
identified in the CT images, beam orientations are chosen 
and beam apertures are accurately delineated using BEV. 
The beam aperture can be fabricated with conventional 
blocks or defined by MLC. The dose distribution within the 
field is determined by choice of beam intensity and simple 
modulators such as wedges and tissue compensators. 
20 tional imaging module adapted to interface with system 10 
and capable of visually displaying an optimal treatment plan 
for delivering radiation to a patient using external beam 
delivery unit 12. Visual evaluation functionality 14 may be 
a computer monitor, a television monitor, any type of 
25 printout from a computer, or any other imaging module used 
by physicians to evaluate the effectiveness of a particular 
treatment plan for a patient. For example, visual evaluation 
functionality 14 may be configured to enable physicians to 
view dose-volume histograms and isodosc surfaces for a 
30 treatment plan overlayed with a diagram of the target 
volume and surrounding areas, including normal surround-
ing tissue and critical structures. 
Three-dimensional imaging system 16 may be any three-
dimensional imaging technology used to delineate target 
NASR is a technique used for treating brain tumors. 
Radiosurgery is distinguished from conventional external 
beam radiation therapy of the central nervous system by its 
localization and treatment strategy. In radiosurgery, the 
target volume of tissue is much smaller (tumors 10-35 mm 
35 volume 20 of a tumor or similar region within a patient, such 
as, for example, a computed tomography (CT) system, a 
magnetic resonance imaging (MRI) system, or any similar 
system. It should be understood by skilled persons in the art 
that there are many ways to capture images of lesions within 
40 a human body, and, therefore, this invention should not be 
limited to any particular type of imaging system. The 
important aspect is that imaging system 16 is capable of 
identifying the contours of target volume 20 along with 
in diameter), the number of fractions (treatment sessions) is 
much less, and the dose per fraction is much larger than in 
conventional radiotherapy. Radiosurgery involves the use of 
external beams of radiation guided to a desired point within 
the brain using a precisely calibrated stereotactic frame 45 
mechanically fixed to the head, a beam delivery unit, such as 
a LINAC Gamma Knife, and three-dimensional medical 
imaging technology. For LINAC radiosurgery, the table on 
which the patient lies and the beam delivery unit are capable 
surrounding normal tissues and critical structures. 
As shown in FIG. 1, system 10 comprises two main 
components: global optimization module 22 and treatment 
plan modeling module 24. FIG. 2 shows an alternative 
embodiment of a system 11 according to the present inven-
tion. System 11 is similar to system 10 except that it 
50 incorporates a third component, dose calculation module 26. of rotating about distinct axes in order to adjust the angle and 
entry point of a radiation beam. The tissue affected by each 
beam is determined by the patient's position within the 
stereotactic frame, by the relative position of the frame in 
relation to the beam delivery unit, by collimators that adjust 
the size of the beam, and by the patient's anatomy. 55 
Additionally, the intensity of each beam can be adjusted to 
govern its dose contribution to each point. 
IMRT is a recently developed treatment modality in 
radiotherapy. In IMRT the beam intensity is varied across 
the treatment field. Rather than being treated with a single, 60 
large, uniform beam, the patient is treated instead with many 
very small beams, each of which can have a different 
intensity. When the tumor is not well separated from the 
surrounding organs at risk-such as what occurs when a 
tumor wraps itself around an organ-there may be no 65 
combination of uniform intensity beams that will safely 
separate the tumor from the healthy organ. In such instances, 
Each of these components will be described in detail below. 
System Input 
Referring again to FIG. 1, system 10 receives various 
inputs from imaging system 16, as well as input data 18. 
Although in the preferred embodiment input data 18 repre-
sents all information input into system 10 not received from 
imaging system 16, it should be noted that input data 18 may 
actually come from any source. For example, input data 18 
may be received by system 10 as a manual input by a 
physician or automatic input via a computer directed by a 
physician. FIG. 1 is merely illustrating by way of example 
that system 10 receives information related to target volume 
20 via imaging system 16 and that all other input is referred 
to as input data 18. 
Input data 18 to system 10 includes CT and/or MRI 
images of target volume 20. The contours of target volume 
US 6,741,674 B2 
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arc a. Then the total radiation dose at a voxel P is given by 
the following expression: 
Equation 1 
20 and surrounding normal tissue and critical structures are 
identified and segmented using the medical images. These 
anatomical contours are used as inputs to system 10. Other 
inputs include clinical planning information such as pre-
scription dose; target lower and upper bounds on the radia- 5 
tion dose delivered to the tumor volume, nearby healthy 
tissue, and critical structures; choice of possible isocenters; 
and desired number of beams, isocenters, and couch angles 
used in the final physical plan. The anatomical contours and 
dose calculation points from the imaging coordinate systems 
are transformed via a coordinate system transformation 
algorithm to the stereotactic coordinate system. An auto-
mated arc selection method employing computational geom-
etry techniques is used to select a representative collection 
where D P,a denotes the dose contribution to voxel P from arc 
10 a as given by the following expression: 
of candidate arcs. 
As described above, system 10 is not limited to a par-
ticular type of apparatus for external beam delivery unit 12 
15 
DP,a~S(C)f s;"'TMR(8,<l>a,i1P,a•'P,a•CP)OAR(8,<j>a,i1P,a•'P.a• 
Cp)IVSQ(8,<j>a,i1P,a•rP,a)d8 Equation 2 
DP a may be calculated using standard dose calculation 
tools 'and merely included with input data 18. As shown in 
FIG. 2, an alternative embodiment of a system 11 may 
employ an internal dose calculation module 26 to perform 
this calculation. Dose calculation module 26 may employ 
or a particular modality. Nonetheless, for exemplary 
purposes, system 10 will be described with respect to a 
preferred method using LINAC arcing radiosurgery. 
In LINAC arcing radiosurgery, the following treatment 
parameters define an arc: a target point location variable t; 
collimator size C, gantry initial and end angles 8;, and 8e and 
couch angle cp. The isocenters for candidate arcs are chosen 
20 computational geometry and measured dosimetry param-
eters in a semi-empirical formulation to calculate Dp a· For 
instance, to calculate the dose from a fixed beam, s~y at a 
point Pin the brain, a ray is formed joining P and a point on 
in 2 mm intervals and reside in the target volume. The 25 
candidate arcs vary the couch and gantry angles in 1 ° 
increments from -90° to 90° and 0° to 359°, respectively. 
These candidate beam orientation parameters (couch and 
gantry angles) are selected so that they match the beam 
orientations selected by clinicians manually. Twelve circular 30 
collimator sizes are applied to the candidate arcs, ranging 
from 12.5 to 40 mm in 2.5 mm steps. The resulting collec-
tion of beams comprise a large set of candidate beams used 
for instantiating a treatment plan optimization model used 
by treatment plan modeling processor 24. 35 
Treatment Plan Optimization Model(freatment Plan 
Modeling Module 
the central axis of the radiation beam. Dose calculation 
module 26 may employ a computation method which uses 
measured dosimetry parameters obtained from a water phan-
tom. The parameters may include: tissue maximum ratios 
(TMR), total scatter correction factors (S), inverse square 
correction (IVSQ), and off-axis ratio (OAR). The depth, d, 
of tissue penetrated by the central ray of the radiation beam, 
and the depth, d, of tissue penetrated by the ray formed by 
connecting the dose calculation voxel P to the radiation 
source are computed by a ray tracing method. The distance, 
r, from the dose calculation voxel to the central ray is also 
computed. Using the values d, d, and r, the measured 
dosimetry parameters are calculated for the point P. The dose 
per monitor unit deposited by one arc of the gantry is the 
sum of a set of static beams which approximate this arc. The 
As shown in FIG. 1 and mentioned above, system 10 
comprises treatment plan modeling module 24 and global 
optimization module 22. Treatment plan modeling module 
40 total dose deposited to a point (DP a) is the summation of the 
dose over all arcs. ' 
24 receives inputs 18, and based on these inputs, creates a 
treatment plan optimization model. The treatment plan opti-
mization model incorporates every potential variable 45 
included within input 18. In other words, the treatment plan 
optimization model represents a global optimization of 
every potential variable within the system. As will be 
described in detail below, upon completion, treatment plan 
modeling module 24 provides the resulting treatment plan 50 
optimization model to global optimization module 22 where 
an optimal treatment plan is determined based on inputs 18. 
The preferred embodiment of the treatment plan optimi-
zation model may also incorporate a variety of desirable 
constraints. For example, clinically prescribed lower and 
upper bounds, say LP and UP, for the radiation dose at voxel 
P can be incorporated with Equation 1 to form the following 
dosimetric constraints: 
NA NA Equation 3 
2= Dp,0 w0 :2::: Lp and 2= Dp,0 w0 ::; Up 
a=l a=l 
Note that a is characterized by the target point, couch angles, 
A preferred embodiment of a treatment plan optimization 
model will now be described. Given a collection of selected 
arcs indexed as { 1, ... , NA}, comprised of target points 55 collimator size, and gantry initial and end angles. Thus, a 
could be more accurately referred to as a; c 8 8 8 . However, 
for brevity of notation, subscripts are list~d ~diy as needed 
to enhance clarity. 
{ 1, ... , NJ and couch angles { 1, ... , Nq,} (note that each 
arc associates with a specified collimator size, gantry initial 
and end angles, target position, and couch angle), the 
preferred treatment plan optimization model incorporates 
non-negative continuous variables to record the intensity 60 
used for each arc. If an arc is used, thus indicating that the 
intensity is greater than zero, then it contributes a certain 
amount of radiation dosage to each voxel in target volume 
20. Thus, once the set of potential arc intensities is specified, 
the total radiation dose received at each voxel can be 65 
modeled. For example, in the preferred treatment plan 
optimization model, wa~O denotes the intensity (weight) of 
The preferred embodiment of the treatment plan optimi-
zation model may also constrain the characteristics of beam 
arrangements from external beam delivery unit 12. To 
control the number of target points specified by the optimal 
plan, the treatment plan optimization model defines a 0/1 
indicator variable t; to denote if target point j is used or not. 
The following constraints capture the use of target point j in 
the resulting plan when an arc with target point j is used. 
US 6,741,674 B2 
9 
N, 




percentage of tumor volume, critical structure and normal 
tissue satisfying their respective target dose levels. Due to 
the proximity of critical structures and the tumor volume, it 
is not possible to find a beam geometry and intensity which 
Here, Ma is a positive constant and can be selected as the 
largest po'ssible beam intensity among candidate arcs having 
target point j. The second constraint can then be imposed, 
where T is the maximum number of target points acceptable 
by the physician for the particular patient. Although com-
plications from radiosurgery treatments may increase with 
the number of isocenters, it has been shown that for highly 
irregular shaped tumor volumes, multiple isocenters may 
improve the conformity of the high dose region. With 
current state of the art methods, determining an "optimal" 
beam configuration with multiple target points is extremely 
difficult and time consuming. The systems and methods of 
the present invention enable clinicians to include such 
constraints within the model to assist in determining an 
optimal treatment plan. 
5 satisfies all the dosimetric constraints given in Equation 3. In 
this case, the treatment plan optimization model may include 
an indicator variable incorporated into each constraint to 
capture whether or not the desired dose bound is achieved. 
Alternatively, the treatment plan optimization model may 
10 
be configured to seek a treatment plan which results in the 
minimum deviation from the clinical prescription bounds. In 
this case, continuous variables can be added to the con-
straints in Equation 3 to measure the deviations from the 
lower and upper bound for each voxel P. 
In the preferred embodiment of the systems and methods 
15 of the present invention, the treatment plan optimization 
model employs a mixed integer programming approach to 
determine an optimal treatment plan which guarantees 100% 
coverage to tumor volume while minimizing the dose 
received by proximal critical structures and/or normal tissue. 
The preferred embodiment of the treatment plan optimi-
zation model may also constrain the number of couch 
angles, and the number of arcs used in the resulting plan due 
20 In particular, instead of providing upper and lower dose 
bounds, the clinician inputs the desired prescription dose 
received by the tumor volume. In this embodiment, the 
treatment plan optimization model formulates the problem 
as: 
Minimize 2= fp 
PEPTV 
to the physical requirement of adjusting the equipment to 
achieve the desired configurations for each round of irra- 25 
diation. For example, the treatment plan optimization model, 
may employ 0/1 integer variable cpj, to model the use of 
couch angle j and 0/1 integer variable ~a to model the use of 
arc a. In this manner, when Wa (wa) is positive, then cpj (~a) 
will be set to 1. These constr~ints may take the following 
form: 
30 Subject to the constraints: 
N¢ 
Wai :;; Na/Pi and 2= <Pi:;; <I> 
j=l 
NA 




where Na and Ra are constants and can be chosen as the 
largest po'ssible intensity emitted from arc a, respectively, 
and <I> and B are the maximum number of couch angles 
allowed and beam configurations desired in the optimal 
35 
40 
plan, respectively. 45 
In a similar manner, the treatment plan optimization 
model may also constrain the collimator size and the number 
of distinct gantry angles used in the resulting plans. In 
addition, it may also impose a minimum beam intensity for 
each arc to ensure that the resulting plan is practical. These 50 
constraints may be important if, in absence of such 
restrictions, the optimization system returns plans involving, 
say, hundreds of distinct configurations. Too many configu-
rations may be physically difficult to manage, and it will be 
impractical to deliver a very complex plan. The treatment 55 
plan optimization model is configured to enable dose cal-
culation module 26 to return a realistic plan which can be 
carried out in a reasonably easy fashion in the treatment 
delivery room. 
The treatment plan optimization model may also incor- 60 
porate additional constraints to enforce clinical properties 
desired for individual patients. A variety of optimization 
objectives can be incorporated with these constraints to 
direct the selection of a treatment plan. For example, one 
possible approach is to find a maximal feasible subsystem 65 
among the dosimetric constraints. Clinically, this translates 
into finding a beam configuration which gives the maximum 
NA 
2= DP.a Wa - fp = PRDOSE PE PTV 
a=l 
N, 
2= t1::; T 
j=l 
Equation 7 
In Equation 7, PRDOSE is the clinical prescription dose for 
the predefined tumor volume PTV, T is the maximum 
number of target points desired by the physicians for the 
particular patient, and <I> and B are the maximum number of 
couch angles allowed and beam configurations desired in the 
optimal plan, respectively. As described above, Ma, Na, and 
Ra are positive constants and can be chosen as the l~rgest 
intensity possible emitted from a single arc. In Equation 7, 
the variable fp denotes the amount of irradiation exceeding 
the prescription dose at point P. Since fp is nonnegative, the 
dose calculation model ensures that point P will receive at 
least the prescription dose. For points P on the tumor 
surface, which separates the tumor volume from the normal 
tissue, in addition to measuring the excess radiation to the 
tumor surface, fp can also be viewed as a measure of 
radiation to the immediately surrounding normal tissue. 
US 6,741,674 B2 
11 
Minimizing the sum of the variables fp has the effect of 
providing a uniform dose distribution on the tumor volume 
while producing a steep dose gradient outside of the tumor 
volume. Thus, even in the absence of a critical structure 
constraining the treatment plan, the dose calculation model 
ensures that proximal normal tissues receive minimal dose 
due to rapid dose fall-off. 
Global Optimization Module 
12 
and-bound is coupled with other computational devices, 
such as problem preprocessing, primal heuristics, global and 
local reduced-cost fixing, and cutting planes. 
In the preferred embodiment, global optimization module 
5 is based on a branch-and-bound MIP solver that is built on 
top of general-purpose mixed integer research code 
(MIPSOL). The general purpose code, which incorporates 
all of the above mentioned computational devices, has been 
shown to be effective in solving a wide variety of large-scale 
real-world MIP instances. 
System Implementation 
System 10 of FIG. 1 and system 11 of FIG. 2 can be 
implemented in hardware, software, firmware, or a combi-
nation thereof. FIG. 3 illustrates a preferred implementation 
of system 11. As described above, system 11 is similar to 
Global optimization module 22 receives the treatment 10 
plan optimization model from treatment plan modeling 
module 24 and input 18. Based on this information, global 
optimization module 22 solves instances of the treatment 
plan optimization model. In the preferred embodiment, a 
classical branch-and-bound approach is used to determine a 15 
true global optimal solution. Moreover, the "intelligent" 
search mechanism of the branch-and-bound method enables 
large sections of the solution space to be eliminated from 
consideration-knowing that no solution within can be 
optimal-without actually examining each solution within. 
system 10 except for the inclusion of dose calculation 
module 26. Thus, although the preferred implementation is 
described below, system 10 is implemented in a similar 
20 fashion. 
The branch-and-bound is a tree search approach where, at 
each node of the tree, certain binary variables are fixed to 
zero or one, and the remaining binary variables are relaxed 
(i.e., allowed to assume any value between zero and one). 
This results in a linear program (LP) being associated with 
each node of the tree. The LP at the root node is simply the 
original 0/1 mixed integer programming (MIP) instance with 
As shown in FIG. 3, system 11 comprises computer 
processing unit (CPU) 28, memory 30, and local interface 
32. System 11 may communicate via local interface 32 with 
25 
input devices 34 and output devices 36. As shown in FIG. 2, 
input devices 34 may include three-dimensional imaging 
system 16 and/or input data 18 and output devices 36 may 
include external beam delivery unit 12 and/or visual evalu-
all of the binary variables relaxed. The tree is constructed 
such that the binary variables fixed in a parent node will be 30 
fixed identically in any of its children, and each child will 
have an additional binary variable fixed to zero or one. 
Typically, children arc formed in pairs as follows. Assume 
that the LP at a given node is solved, and one or more of the 
relaxed binary variables is fractional in the optimal solution. 35 
One selects such a fractional binary variable and branches 
ation functionality 14. 
Treatment plan modeling module 24, global optimization 
module 22, and dose calculation module 26 are implemented 
software or firmware that is stored in memory 30 and 
executed by CPU 28. CPU 28 may be any suitable instruc-
tion execution system. It should be understood by persons 
skilled in the art that treatment plan modeling module 24, 
global optimization module 22, and dose calculation module 
on it. In other words, two child nodes are formed; one with 
the selected binary variable fixed to zero, and the other with 
the selected binary variable fixed to one. Of course, each 
child also inherits all of the fixed binary variables of its 40 
parent. Note that the objective value of a child node can be 
26 may also implemented in hardware. For example, in 
accordance with the systems and methods of the present 
invention, treatment plan modeling module 24, global opti-
mization module 22, and dose calculation module 26 may be 
implemented with any or a combination of the following 
no smaller (in the case of minimization) than the objective 
value of its parent. 
If the linear program at a given node is solved and the 
optimal solution happens to have integral values for all the 
relaxed binary variables, then this solution is feasible for the 
original 0/1 mixed integer program. Once a feasible solution 
for the original problem is found, the associated objective 
value can be used as an upper bound (in the case of 
minimization) for the objective values of LP's at other 
nodes. In particular, if an LP at another node is solved, and 
its objective value is greater than or equal to the upper 
bound, then none of its children could yield a feasible 
solution for the original MIP with a smaller objective value 
than the one already obtained. Hence, no further exploration 
of this other node is needed, and the node is said to be 
fathomed. 
Two other criteria for fathoming a node are apparent: if 
the associated LP is infeasible, or if the optimal solution of 
the LP has integral values for all relaxed binary variables, 
then no further exploration of the node is required. In the 
latter case, the optimal objective value of the LP will be 
compared with the current upper bound, and the upper 
bound will be updated if needed. The tree search ends when 
all nodes are fathomed. Although a variety of strategies may 
be used for intelligently selecting branching variables and 
nodes to process, in the preferred embodiment, the branch-
technologies, which are all well known in the art: a discrete 
logic circuit(s) having logic gates for implementing logic 
functions upon data signals, an application specific inte-
45 grated circuit (ASIC) having appropriate combinational 
logic gates, a programmable gate array(s) (PGA), a field 
programmable gate array (FPGA), etc. 
The flowchart of FIG. 4 shows the functionality and 
operation of one implementation of system 11. Any process 
50 descriptions or blocks in flowcharts should be understood as 
representing modules, segments, or portions of code which 
include one or more executable instructions for implement-
ing specific logical functions or steps in the process, and 
alternate implementations are included within the scope of 
55 the preferred embodiment of the present invention in which 
functions may be executed out of order from that shown or 
discussed, including substantially concurrently or in reverse 
order, depending on the functionality involved, as would be 
understood by those reasonably skilled in the art of the 
60 present invention. 
Referring to FIG. 4, at 34, information related to the 
prescribed dose is received. At 36, information related to 
target volume 20 is received. As described above, this 
information may include CT and/or MRI images identifying 
65 the contours of target volume 20 and surrounding normal 
tissue and critical structures. Information related to external 
beam delivery unit 12, such as beam geometry and beam 
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parameters, is received at 38. At 40, information related to 
the constraints to be incorporated into the treatment plan 
optimization model is received. For example, the treatment 
plan optimization model may incorporate dosimetric con-
straints and constraints on various characteristics of the 5 
beam arrangements. At 42, predefined clinical objectives are 
received. At 44, the variables to include in the treatment plan 
optimization model are determined. As described above, the 
present invention employs a global approach, and thus, all 
possible variables are included in the treatment plan opti- 10 
mization model. At 46, the type of variable for each variable 
is determined, for example, whether the variable will be 
represented in the treatment plan optimization model as a 
non-negative continuous variable or a 0/1 integer variable. 
14 
read-only memory (CDROM) (optical). Note that the 
computer-readable medium could even be paper or another 
suitable medium upon which the program is printed, as the 
program can be electronically captured, via for instance 
optical scanning of the paper or other medium, then 
compiled, interpreted or otherwise processed in a suitable 
manner if necessary, and then stored in a computer memory. 
It should be emphasized that the above-described embodi-
ments of the present invention, particularly, any "preferred" 
embodiments, are merely possible examples of 
implementations, merely set forth for a clear understanding 
of the principles of the invention. Many variations and 
modifications may be made to the above-described embodi-
ments of the invention without departing substantially from 
the spirit and principles of the invention. All such modifi-
cations and variations are intended to be included herein 
within the scope of this disclosure and the present invention 
and protected by the following claims. 
At 48, the treatment plan optimization model is determined 15 
by incorporating the variables, constraints, and the clinical 
objective into a global mathematical expression. At 50, a 
branch-and-bound algorithm is used to determine the opti-
mal treatment plan. Therefore, having thus described the invention, at least 
20 the following is claimed: Treatment plan modeling module 24, global optimization 
module 22, and dose calculation module 26, which comprise 
an ordered listing of executable instructions for implement-
ing logical functions, can be embodied in any computer-
readable medium for use by or in connection with CPU 28 
or any other instruction execution system, apparatus, or 25 
device, such as a computer-based system, processor-
containing system, or other system that can fetch the instruc-
tions from the instruction execution system, apparatus, or 
device and execute the instructions. In the context of this 
document, a "computer-readable medium" can be any 30 
means that can contain, store, communicate, propagate, or 
transport the program for use by or in connection with the 
instruction execution system, apparatus, or device. The 
computer-readable medium can be, for example but not 
limited to, an electronic, magnetic, optical, electromagnetic, 35 
infrared, or semiconductor system, apparatus, device, or 
propagation medium. More specific examples (a nonexhaus-
tive list) of the computer-readable medium would include 
the following: an electrical connection (electronic) having 
one or more wires, a portable computer diskette (magnetic), 40 
a random access memory (RAM) (electronic), a read-only 
memory (ROM) (electronic), an erasable programmable 
read-only memory (EPROM or Flash memory) (electronic), 
an optical fiber (optical), and a portable compact disc 
1. A method of providing an optimal treatment plan in 
external beam radiation therapy, the method comprising the 
steps of: 
a. receiving (1) patient image scan data, (2) a prescription 
radiation dose for a predefined patient target volume, 
(3) a plurality of beam profile properties, ( 4) at least 
one clinical property, and (5) at least one clinical 
objective; 
b. developing a mathematical formulation that optimizes 
the at least one clinical objective subject to the (1) 
patient image scan data, (2) the prescription radiation 
dose for the predefined patient target volume, (3) the 
plurality of beam profile properties, and ( 4) the at least 
one clinical property; and 
c. determine a globally optimal solution to the mathemati-
cal formulation. 
2. The method of claim 1, wherein the plurality of beam 
profile properties relate to intensity modulated radiation 
therapy. 
3. The method of claim 2, wherein the plurality of beam 
profile properties comprise one of a beamlet variable and a 
beam variable. 
* * * * * 
